AnaptysBio
ANAB
ANAB
122 hedge funds and large institutions have $670M invested in AnaptysBio in 2020 Q2 according to their latest regulatory filings, with 25 funds opening new positions, 30 increasing their positions, 45 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
4.57% less ownership
Funds ownership: 114.53% → 109.96% (-4.6%)
33% less repeat investments, than reductions
Existing positions increased: 30 | Existing positions reduced: 45
84% less call options, than puts
Call options by funds: $574K | Put options by funds: $3.51M
Holders
122
Holding in Top 10
6
Calls
$574K
Puts
$3.51M
Top Buyers
| 1 | +$12.8M | |
| 2 | +$6.24M | |
| 3 | +$5.4M | |
| 4 |
TCM
Tang Capital Management
San Diego,
California
|
+$5.31M |
| 5 |
Goldman Sachs
New York
|
+$5.31M |
Top Sellers
| 1 | -$11.6M | |
| 2 | -$10.8M | |
| 3 | -$8.84M | |
| 4 |
PA
Perceptive Advisors
New York
|
-$7.07M |
| 5 |
KAM
Krensavage Asset Management
New York
|
-$5.79M |